Patients previously treated for prostate cancer with radical prostatectomy and now having a biochemical recurrence (BCR) defined as: PSA \>0.2 \<2.0 ng/mL, and increasing measured twice.
Multidisciplinary conference (MDK) decision to offer the patient SRT
Signed Informed Consent
You may not be if
Patients previously treated for prostate cancer with biochemical recurrence
Previous treatment with androgen deprivation therapy (ADT) after surgery
Previous pelvic radiotherapy
Patients with positive lymph nodes at surgery
Clareo Health | Comparing "Salvage" Radiotherapy and Individualized PSMA PET/CT Targeted Treatment in With Relapsing Prostate Cancer
